TABLE 7.

P. falciparum SP treatment failure in vivo for selected countries in Asia, 1996 to 2002

RegionCountryNo. of data points identifiedPeriodAge range (yr)Outcome classificationPeriod of follow-up (days)Median %SP-PF (range)aMedian %SP-TTF (range)aSource or reference
East AsiaIndonesia21992-1999AllWHO 19732843 (15-71)9 76, 124
Malaysia119965-51WHO 19732847 117
Myanmar21995AllDay 28 clinical failure, WHO 19732867 (64-70)19 (18-20) 190
Myanmar11995AllWHO 19961435 62
Pakistan11994AllWHO 1973285 179
  • a SP-PF, SP parasitologic failure (either R1-R3 or cumulative parasite failure); SP-TTF, SP clinical failure (either ETF + LTF or cumulative clinical failure).